Bethlehem marks sombre Christmas under shadow of war
7 tips to prepare for next year’s taxes nowTulane vs. Wyoming Predictions & Picks: Spread, Total – November 26STRATA Skin Sciences ( NASDAQ:SSKN – Get Free Report ) and Delcath Systems ( NASDAQ:DCTH – Get Free Report ) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, risk, profitability, earnings and analyst recommendations. Institutional and Insider Ownership 32.4% of STRATA Skin Sciences shares are owned by institutional investors. Comparatively, 61.1% of Delcath Systems shares are owned by institutional investors. 39.0% of STRATA Skin Sciences shares are owned by company insiders. Comparatively, 17.9% of Delcath Systems shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Volatility and Risk STRATA Skin Sciences has a beta of 1.32, meaning that its share price is 32% more volatile than the S&P 500. Comparatively, Delcath Systems has a beta of 0.75, meaning that its share price is 25% less volatile than the S&P 500. Analyst Recommendations Delcath Systems has a consensus target price of $21.50, indicating a potential upside of 120.29%. Given Delcath Systems’ stronger consensus rating and higher probable upside, analysts plainly believe Delcath Systems is more favorable than STRATA Skin Sciences. Earnings & Valuation This table compares STRATA Skin Sciences and Delcath Systems”s gross revenue, earnings per share and valuation. STRATA Skin Sciences has higher revenue and earnings than Delcath Systems. Delcath Systems is trading at a lower price-to-earnings ratio than STRATA Skin Sciences, indicating that it is currently the more affordable of the two stocks. Profitability This table compares STRATA Skin Sciences and Delcath Systems’ net margins, return on equity and return on assets. Summary STRATA Skin Sciences beats Delcath Systems on 8 of the 14 factors compared between the two stocks. About STRATA Skin Sciences ( Get Free Report ) STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions. It also offers TheraClear Acne Therapy System for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania. About Delcath Systems ( Get Free Report ) Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company’s lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. It also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York. Receive News & Ratings for STRATA Skin Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STRATA Skin Sciences and related companies with MarketBeat.com's FREE daily email newsletter .
The Atlanta Braves are in somewhat unfamiliar territory. Atlanta has been great in recent years and has had a very solid core. Most of the team's top pieces have stuck together but changes could come this offseason. All-Star starting pitcher Max Fried is one of the most sought-after free agents on the open market and it's unclear if he will sign back. It seems unlikely at this point but there will be options to replace him. Newsweek's Zach Pressnell put together a list of six options to replace Fried and suggested that the Braves pull off a blockbuster trade with the Chicago White Sox for Garrett Crochet. "(Left-handed pitcher) Garrett Crochet, Chicago White Sox," Pressnell said. "If the Braves are exploring the trade market, they could look to acquire the best arm on the market: Chicago White Sox ace Garrett Crochet. "Crochet would require a huge haul to acquire, but that's something the Braves could explore. The flamethrowing southpaw would provide the Braves with one of the higher potential starters in the game. Atlanta likely doesn't have the farm system to comfortably make this deal, but it's something worth exploring for sure." Crochet is a fellow left-handed All-Star and would cost significantly less. He is projected to make $2.9 million in 2025 and is under team control for the 2026 season as well. It would be tough to part with enough prospects to bring Crochet to town, but if Fried leaves maybe the Braves would consider such a move. More MLB: Braves urged to sign projected $60M star if Max Fried cuts ties with ATLSan Jose Sharks, who host Los Angeles Kings on Monday, activate center Nico Sturm off injured reserveThere isn’t a galaxy far, far away enough where women can escape sexist online trolls. Emily Calandrelli became the 100th woman to go to space when she joined a group of six space tourists in a launch led by Blue Origin , the aerospace company owned by the billionaire Jeff Bezos. “We got to weightlessness, I immediately turned upside down and looked at the planet and then there was so much blackness. There was so much space,” Calandrelli said in a video posted to social media that showed her reacting with awe to seeing Earth from space. She added: “I didn’t expect to see so much space, and I kept saying that’s our planet! That’s our planet! It was the same feeling I got when my kids were born, and I was like, ‘That’s my baby!’” But it was not long before the comments beneath the video were flooded with hateful, objectifying remarks. The astronaut and MIT engineer said some sexualized her reaction to viewing the planet from space. The incident led to Blue Origin taking down the original video from its social media accounts. Calandrelli, who also hosts a television show on Netflix called Emily’s Wonder Lab, where she’s known as “Space Gal”, said the reactions made her sad and angry, but she doubled down on her joy. In an Instagram post , she wrote she refuses “to give much time to the small men on the internet. “I feel experiences in my soul. It’s a trait I got from my father,” she said. “We feel every emotion deeply and what a beautiful way that is to experience life. This joy is tattooed on my heart.” “I will not apologize or feel weird about my reaction. It’s wholly mine and I love it.” Calandrelli said in an interview with CNN that the beauty of sending more women into space is that they “get to describe it in a way that moms can understand, that women can understand”. Blue Origin did not respond to a request for comment.
Budget tax raid will put us off hiring, say bosses
Friendly reminder |
The authenticity of this information has not been verified by this website and is for your reference only. Please do not reprint without permission. If authorized by this website, it should be used within the scope of authorization and marked with "Source: this website". |
Special attention |
Some articles on this website are reprinted from other media. The purpose of reprinting is to convey more industry information, which does not mean that this website agrees with their views and is responsible for their authenticity. Those who make comments on this website forum are responsible for their own content. This website has the right to reprint or quote on the website. The comments on the forum do not represent the views of this website. If you need to use the information provided by this website, please contact the original author. The copyright belongs to the original author. If you need to contact this website regarding copyright, please do so within 15 days. |